Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development

Journal of Neuroimmunology

Volumn 95, Issue 1-2, 1999, Pages 195-201

  Fiten, Pierre ^a   Vandenbroeck, Koen ^a   DuBois, Bénédicte ^a   Van Coillie, Els ^a   Nelissen, Inge ^a   Van Damme, Jo ^a   Ligers, Arturs ^b   Hillert, Jan ^b   Andersson, Magnus ^c   Olsson, Tomas ^c   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b Dept Clin Neurosci Huddinge U ^*  (Sweden)

^c Center for Molecular Medicine   (Sweden)

Author keywords

Chemokine; HLA stratification; Microsatellite; Multiple sclerosis; Polymorphism

Indexed keywords

CHEMOKINE; MICROSATELLITE DNA; MONOCYTE CHEMOTACTIC PROTEIN 3;

ADULT; AGED; ALLELE; ARTICLE; AUTOMATION; ENHANCER REGION; FEMALE; FLUORESCENCE; GENE FREQUENCY; GENETIC POLYMORPHISM; HLA SYSTEM; HUMAN; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION;

ALLELES; CYTOKINES; DNA PROBES; DNA, SATELLITE; ENHANCER ELEMENTS (GENETICS); HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; MONOCYTE CHEMOATTRACTANT PROTEINS; MULTIPLE SCLEROSIS; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 0033103732     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00007-7     Document Type: Article

References (33)

1. Barnes D.A., Huston M., Holmes R., Benveniste E.N., Wee Yong V., Scholz P., Perez H.D. Induction of RANTES expression by astrocytes and astrocytoma cell lines. J. Neuroimmunol. 71:1996;207-214.
2. Berman J.W., Guida M.P., Warren J., Amat J., Brosnan C.F. Localization of monocyte chemoattractant peptide: 1. Expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J. Immunol. 156:1996;3017-3023.
3. Croxton, F.E., 1953. Elementary Statistics with Applications in Medicine, Chap. 14. Prentice-Hall, New York, pp. 267-283.
4. Ebers G.C., Kukay K.et al. A full genome search in multiple sclerosis. Nat. Genet. 13:1996;472-476.
5. Epplen C., Jäckel S., Santos E.J.M., D'Souza M., Poehlau D., Dotzauer B., Sindern E., Haupts M., Rüde K.-P., Weber F., Stöver J., Poser S., Gehler W., Malin J.-P., Przuntek H., Epplen J.T. Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann. Neurol. 41:1997;341-352.
6. Glabinski A.R., Tani M., Tuohy V.K., Tuthill R.J., Ransohoff R.M. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain Behav. Immun. 9:1995;315-320.
7. Glabinski A.R., Balasingam V., Tani M., Kunkel S.L., Strieter R.M., Wee Yong V., Ransohoff R.M. Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J. Immunol. 156:1996;4363-4368.
8. Glabinski A.R., Tani M., Strieter R.M., Tuohy V.K., Ransohoff R.M. Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am. J. Pathol. 150:1997;617-630.
9. Godiska R., Chantry D., Dietsch G.N., Gray P.W. Chemokine expression in murine experimental allergic encephalomyelitis. J. Neuroimmunol. 58:1995;167-176.
10. Hayashi M., Luo Y., Laning J., Strieter R.M., Dorf M.E. Production and function of monocyte chemoattractant protein-1 and other β-chemokines in murine glial cells. J. Neuroimmunol. 60:1995;143-150.
11. Hillert, J., 1996. Genetics of multiple sclerosis. In: S.D. Cook (Ed.), Handbook of Multiple Sclerosis. Marcel Dekker, New York, pp. 19-21.
12. Hillert J., Olerup O. Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on normal DR15, DQ6, Dw2 haplotype. Neurology. 43:1993;163-168.
13. Hulkower K., Brosnan C.F., Aquino D.A., Cammer W., Kulshretha S., Guida M.P., Rapoport D.A., Berman J.W. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J. Immunol. 150:1993;2525-2533.
14. Karpus W.J., Lukacs N.W., McRae B.L., Strieter R.M., Kunkel S.L., Miller S.D. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155:1995;5003-5010.
15. Kuokkanen S., Sundvall M., Terwilliger J.D., Tienari P.J., Wikström J., Holmdahl R., Pettersson U., Peltonen L. A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nat. Genet. 13:1996;477-480.
16. Kuokkanen S., Gschwend M., Rioux J.D., Daly M.J., Terwilliger J.D., Tienari P.J., Wikstrom J., Palo J., Stein L.D., Hudson T.J., Lander E.S., Peltonen L. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am. J. Hum. Genet. 61:1997;1379-1387.
17. Luster, A.D., 1998. Chemokines - Chemotactic cytokines that mediate inflammation. New Engl. J. Med., 436-445.
18. McManus C., Berman J.W., Brett F.M., Staunton H., Farrell M., Brosnan C.F. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J. Neuroimmunol. 86:1998;20-29.
19. Miyagishi R., Kikuchi S., Fukuzawa T., Tashiro K. Macrophage inflammatory protein-1 alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. J. Neurol. Sci. 129:1995;223-227.
20. Murakami K., Nomiyama H., Miura R., Follens A., Fiten P., Van Coillie E., Van Damme J., Opdenakker G. Structural and functional analysis of the promoter region of the human MCP-3 gene: transactivation of expression by novel recognition sequences adjacent to the transcription initiation site. DNA Cell Biol. 16:1997;173-183.
21. Naruse K., Ueno M., Satoh T., Nomiyama H., Tei H., Takeda M., Ledbetter D.H., Van Coillie E., Opdenakker G., Gunge N., Sakaki Y., Iio M., Miura R. A YAC contig of the human CC chemokine genes clustered on chromosome 17q11.2. Genomics. 34:1996;236-240.
22. Olerup O., Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 39:1992;225-235.
23. Opdenakker G., Van Damme J. Cytokine-regulated proteases in autoimmune diseases. Immunol. Today. 15:1994;103-107.
24. Opdenakker G., Fiten P., Nys G., Froyen G., Van Roy N., Speleman F., Laureys G., Van Damme J. The human MCP-3 gene (SCYA7): cloning, sequence analysis, and assignment to the C-C chemokine gene cluster on chromosome 17q11.2-q12. Genomics. 21:1994;403-408.
25. Raine C.S. The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion. Ann. Neurol. 36:1994;S61-S72.
26. Sawcer S., Jones H.B., Feakes R., Gray J., Smaldon N., Chataway J., Robertson N., Clayton D., Goodfellow P.N., Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat. Genet. 13:1996;464-468.
27. Simpson J.E., Newcombe J., Cuzner M.L., Woodroofe M.N. Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J. Neuroimmunol. 84:1998;238-249.
28. Taub D.D., Proost P., Murphy W.J., Anver M., Longo D.L., Van Damme J., Oppenheim J.J. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J. Clin. Invest. 95:1995;1370-1376.
29. The Multiple Sclerosis Genetics Group A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat. Genet. 13:1996;469-471.
30. Tienari P.J., Wikström J., Sajantila A., Palo J., Peltonen L. Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Lancet. 340:1992;987-991.
31. Van Damme J., Proost P., Lenaerts J.-P., Opdenakker G. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J. Exp. Med. 176:1992;59-65.
32. Vandenbroeck K., Martino G., Marrosu M.G., Consiglio A., Zaffaroni M., Vaccargiu S., Franciotta D., Ruggeri M., Comi G., Grimaldi L.M.E. Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis. J. Neuroimmunol. 76:1997;189-192.
33. Woolf B. On estimating the relation between blood group and disease. Ann. Hum. Genet. 19:1955;251-253.